Yuka Matsuzaki

Title: Yuka Matsuzaki: Innovator in Dose Evaluation Systems

Introduction

Yuka Matsuzaki is a notable inventor based in Sapporo, Japan. He has made significant contributions to the field of medical technology, particularly in the area of dose evaluation systems for proton irradiation therapy. His innovative work aims to enhance the precision and effectiveness of cancer treatment.

Latest Patents

Matsuzaki holds a patent for a dose evaluation system, planning system, particle irradiation system, and dose evaluation method. This invention provides a function for recording marker position data and spot data. The marker position data includes information on the position of a marker measured for tumor tracking irradiation and the timing of X-ray imaging execution. The spot data encompasses details on the timing of irradiation for each spot, the delivered irradiation position, and the amount of irradiation delivered. By synchronizing the marker position data and spot data based on time information, the system calculates the delivered dose distribution of proton irradiation. This configuration allows for consideration of the interplay effect, supporting more appropriate determinations during the replanning of treatment plans. Matsuzaki's patent is a significant advancement in the field of radiation therapy.

Career Highlights

Throughout his career, Yuka Matsuzaki has worked with prominent organizations such as Hitachi, Ltd. and Hokkaido University. His experience in these institutions has contributed to his expertise in medical technology and innovation.

Collaborations

Matsuzaki has collaborated with notable colleagues, including Yusuke Vincent Fujii and Taeko Matsuura. These partnerships have fostered a collaborative environment that encourages innovation and the development of advanced medical technologies.

Conclusion

Yuka Matsuzaki's contributions to dose evaluation systems represent a significant advancement in cancer treatment technology. His innovative patent and collaborative efforts highlight his commitment to improving medical practices. His work continues to influence the field and offers hope for more effective cancer therapies in the future.